A Study of APL-10456-Vaccine

NCT07399132 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinovirus

Interventions

DRUG: APL-10456-Vaccine
OTHER: Placebo

Sponsor

Apollo Therapeutics Ltd